Clinical Trial Update: Clinical Utility of Early vs. Late Blood Biomarker Testing for Alzheimer's Disease [NA]

View source ↗

Summary

A clinical trial evaluating early versus late blood biomarker testing for Alzheimer's disease has been withdrawn, with no results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: C2N Diagnostics | Conditions: Alzheimers Disease | NA | Status: WITHDRAWN